Global RNA Oligonucleotide Synthesis Service Supply, Demand and Key Producers, 2023-2029
The global RNA Oligonucleotide Synthesis Service market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global RNA Oligonucleotide Synthesis Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for RNA Oligonucleotide Synthesis Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of RNA Oligonucleotide Synthesis Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global RNA Oligonucleotide Synthesis Service total market, 2018-2029, (USD Million)
Global RNA Oligonucleotide Synthesis Service total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: RNA Oligonucleotide Synthesis Service total market, key domestic companies and share, (USD Million)
Global RNA Oligonucleotide Synthesis Service revenue by player and market share 2018-2023, (USD Million)
Global RNA Oligonucleotide Synthesis Service total market by Type, CAGR, 2018-2029, (USD Million)
Global RNA Oligonucleotide Synthesis Service total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global RNA Oligonucleotide Synthesis Service market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GenScript, OriGene, BBI, Genewiz, Eurofins Genomics, Gene Oracle, SBS Genetech, Creative Biolabs and Bio Basic, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World RNA Oligonucleotide Synthesis Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global RNA Oligonucleotide Synthesis Service Market, By Region:
1. How big is the global RNA Oligonucleotide Synthesis Service market?
2. What is the demand of the global RNA Oligonucleotide Synthesis Service market?
3. What is the year over year growth of the global RNA Oligonucleotide Synthesis Service market?
4. What is the total value of the global RNA Oligonucleotide Synthesis Service market?
5. Who are the major players in the global RNA Oligonucleotide Synthesis Service market?
6. What are the growth factors driving the market demand?
This report studies the global RNA Oligonucleotide Synthesis Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for RNA Oligonucleotide Synthesis Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of RNA Oligonucleotide Synthesis Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global RNA Oligonucleotide Synthesis Service total market, 2018-2029, (USD Million)
Global RNA Oligonucleotide Synthesis Service total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: RNA Oligonucleotide Synthesis Service total market, key domestic companies and share, (USD Million)
Global RNA Oligonucleotide Synthesis Service revenue by player and market share 2018-2023, (USD Million)
Global RNA Oligonucleotide Synthesis Service total market by Type, CAGR, 2018-2029, (USD Million)
Global RNA Oligonucleotide Synthesis Service total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global RNA Oligonucleotide Synthesis Service market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GenScript, OriGene, BBI, Genewiz, Eurofins Genomics, Gene Oracle, SBS Genetech, Creative Biolabs and Bio Basic, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World RNA Oligonucleotide Synthesis Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global RNA Oligonucleotide Synthesis Service Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Standard Oligonucleotides
- Micro-Oligonucleotides
- Large-scale Oligonucleotides
- Degenerate Primers
- Long Oligos Synthesis
- Commercial
- Academic Research
- GenScript
- OriGene
- BBI
- Genewiz
- Eurofins Genomics
- Gene Oracle
- SBS Genetech
- Creative Biolabs
- Bio Basic
- Kaneka Eurogentec SA
- AltaBioscience
- Synbio Technologies
- TriLink
- Azenta Life Science
- KareBay Biochem
- Creative Biogene
- Generi Biotech
- Primetech
- General Biosystems
1. How big is the global RNA Oligonucleotide Synthesis Service market?
2. What is the demand of the global RNA Oligonucleotide Synthesis Service market?
3. What is the year over year growth of the global RNA Oligonucleotide Synthesis Service market?
4. What is the total value of the global RNA Oligonucleotide Synthesis Service market?
5. Who are the major players in the global RNA Oligonucleotide Synthesis Service market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 RNA Oligonucleotide Synthesis Service Introduction
1.2 World RNA Oligonucleotide Synthesis Service Market Size & Forecast (2018 & 2022 & 2029)
1.3 World RNA Oligonucleotide Synthesis Service Total Market by Region (by Headquarter Location)
1.3.1 World RNA Oligonucleotide Synthesis Service Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States RNA Oligonucleotide Synthesis Service Market Size (2018-2029)
1.3.3 China RNA Oligonucleotide Synthesis Service Market Size (2018-2029)
1.3.4 Europe RNA Oligonucleotide Synthesis Service Market Size (2018-2029)
1.3.5 Japan RNA Oligonucleotide Synthesis Service Market Size (2018-2029)
1.3.6 South Korea RNA Oligonucleotide Synthesis Service Market Size (2018-2029)
1.3.7 ASEAN RNA Oligonucleotide Synthesis Service Market Size (2018-2029)
1.3.8 India RNA Oligonucleotide Synthesis Service Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 RNA Oligonucleotide Synthesis Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 RNA Oligonucleotide Synthesis Service Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029)
2.2 World RNA Oligonucleotide Synthesis Service Consumption Value by Region
2.2.1 World RNA Oligonucleotide Synthesis Service Consumption Value by Region (2018-2023)
2.2.2 World RNA Oligonucleotide Synthesis Service Consumption Value Forecast by Region (2024-2029)
2.3 United States RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029)
2.4 China RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029)
2.5 Europe RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029)
2.6 Japan RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029)
2.7 South Korea RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029)
2.8 ASEAN RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029)
2.9 India RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029)
3 WORLD RNA OLIGONUCLEOTIDE SYNTHESIS SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World RNA Oligonucleotide Synthesis Service Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global RNA Oligonucleotide Synthesis Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for RNA Oligonucleotide Synthesis Service in 2022
3.2.3 Global Concentration Ratios (CR8) for RNA Oligonucleotide Synthesis Service in 2022
3.3 RNA Oligonucleotide Synthesis Service Company Evaluation Quadrant
3.4 RNA Oligonucleotide Synthesis Service Market: Overall Company Footprint Analysis
3.4.1 RNA Oligonucleotide Synthesis Service Market: Region Footprint
3.4.2 RNA Oligonucleotide Synthesis Service Market: Company Product Type Footprint
3.4.3 RNA Oligonucleotide Synthesis Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: RNA Oligonucleotide Synthesis Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: RNA Oligonucleotide Synthesis Service Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: RNA Oligonucleotide Synthesis Service Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: RNA Oligonucleotide Synthesis Service Consumption Value Comparison
4.2.1 United States VS China: RNA Oligonucleotide Synthesis Service Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: RNA Oligonucleotide Synthesis Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based RNA Oligonucleotide Synthesis Service Companies and Market Share, 2018-2023
4.3.1 United States Based RNA Oligonucleotide Synthesis Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies RNA Oligonucleotide Synthesis Service Revenue, (2018-2023)
4.4 China Based Companies RNA Oligonucleotide Synthesis Service Revenue and Market Share, 2018-2023
4.4.1 China Based RNA Oligonucleotide Synthesis Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies RNA Oligonucleotide Synthesis Service Revenue, (2018-2023)
4.5 Rest of World Based RNA Oligonucleotide Synthesis Service Companies and Market Share, 2018-2023
4.5.1 Rest of World Based RNA Oligonucleotide Synthesis Service Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies RNA Oligonucleotide Synthesis Service Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World RNA Oligonucleotide Synthesis Service Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Standard Oligonucleotides
5.2.2 Micro-Oligonucleotides
5.2.3 Large-scale Oligonucleotides
5.2.4 Degenerate Primers
5.2.5 Long Oligos Synthesis
5.3 Market Segment by Type
5.3.1 World RNA Oligonucleotide Synthesis Service Market Size by Type (2018-2023)
5.3.2 World RNA Oligonucleotide Synthesis Service Market Size by Type (2024-2029)
5.3.3 World RNA Oligonucleotide Synthesis Service Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World RNA Oligonucleotide Synthesis Service Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Commercial
6.2.2 Academic Research
6.3 Market Segment by Application
6.3.1 World RNA Oligonucleotide Synthesis Service Market Size by Application (2018-2023)
6.3.2 World RNA Oligonucleotide Synthesis Service Market Size by Application (2024-2029)
6.3.3 World RNA Oligonucleotide Synthesis Service Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 GenScript
7.1.1 GenScript Details
7.1.2 GenScript Major Business
7.1.3 GenScript RNA Oligonucleotide Synthesis Service Product and Services
7.1.4 GenScript RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 GenScript Recent Developments/Updates
7.1.6 GenScript Competitive Strengths & Weaknesses
7.2 OriGene
7.2.1 OriGene Details
7.2.2 OriGene Major Business
7.2.3 OriGene RNA Oligonucleotide Synthesis Service Product and Services
7.2.4 OriGene RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 OriGene Recent Developments/Updates
7.2.6 OriGene Competitive Strengths & Weaknesses
7.3 BBI
7.3.1 BBI Details
7.3.2 BBI Major Business
7.3.3 BBI RNA Oligonucleotide Synthesis Service Product and Services
7.3.4 BBI RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 BBI Recent Developments/Updates
7.3.6 BBI Competitive Strengths & Weaknesses
7.4 Genewiz
7.4.1 Genewiz Details
7.4.2 Genewiz Major Business
7.4.3 Genewiz RNA Oligonucleotide Synthesis Service Product and Services
7.4.4 Genewiz RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Genewiz Recent Developments/Updates
7.4.6 Genewiz Competitive Strengths & Weaknesses
7.5 Eurofins Genomics
7.5.1 Eurofins Genomics Details
7.5.2 Eurofins Genomics Major Business
7.5.3 Eurofins Genomics RNA Oligonucleotide Synthesis Service Product and Services
7.5.4 Eurofins Genomics RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Eurofins Genomics Recent Developments/Updates
7.5.6 Eurofins Genomics Competitive Strengths & Weaknesses
7.6 Gene Oracle
7.6.1 Gene Oracle Details
7.6.2 Gene Oracle Major Business
7.6.3 Gene Oracle RNA Oligonucleotide Synthesis Service Product and Services
7.6.4 Gene Oracle RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Gene Oracle Recent Developments/Updates
7.6.6 Gene Oracle Competitive Strengths & Weaknesses
7.7 SBS Genetech
7.7.1 SBS Genetech Details
7.7.2 SBS Genetech Major Business
7.7.3 SBS Genetech RNA Oligonucleotide Synthesis Service Product and Services
7.7.4 SBS Genetech RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 SBS Genetech Recent Developments/Updates
7.7.6 SBS Genetech Competitive Strengths & Weaknesses
7.8 Creative Biolabs
7.8.1 Creative Biolabs Details
7.8.2 Creative Biolabs Major Business
7.8.3 Creative Biolabs RNA Oligonucleotide Synthesis Service Product and Services
7.8.4 Creative Biolabs RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Creative Biolabs Recent Developments/Updates
7.8.6 Creative Biolabs Competitive Strengths & Weaknesses
7.9 Bio Basic
7.9.1 Bio Basic Details
7.9.2 Bio Basic Major Business
7.9.3 Bio Basic RNA Oligonucleotide Synthesis Service Product and Services
7.9.4 Bio Basic RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Bio Basic Recent Developments/Updates
7.9.6 Bio Basic Competitive Strengths & Weaknesses
7.10 Kaneka Eurogentec SA
7.10.1 Kaneka Eurogentec SA Details
7.10.2 Kaneka Eurogentec SA Major Business
7.10.3 Kaneka Eurogentec SA RNA Oligonucleotide Synthesis Service Product and Services
7.10.4 Kaneka Eurogentec SA RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Kaneka Eurogentec SA Recent Developments/Updates
7.10.6 Kaneka Eurogentec SA Competitive Strengths & Weaknesses
7.11 AltaBioscience
7.11.1 AltaBioscience Details
7.11.2 AltaBioscience Major Business
7.11.3 AltaBioscience RNA Oligonucleotide Synthesis Service Product and Services
7.11.4 AltaBioscience RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 AltaBioscience Recent Developments/Updates
7.11.6 AltaBioscience Competitive Strengths & Weaknesses
7.12 Synbio Technologies
7.12.1 Synbio Technologies Details
7.12.2 Synbio Technologies Major Business
7.12.3 Synbio Technologies RNA Oligonucleotide Synthesis Service Product and Services
7.12.4 Synbio Technologies RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Synbio Technologies Recent Developments/Updates
7.12.6 Synbio Technologies Competitive Strengths & Weaknesses
7.13 TriLink
7.13.1 TriLink Details
7.13.2 TriLink Major Business
7.13.3 TriLink RNA Oligonucleotide Synthesis Service Product and Services
7.13.4 TriLink RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 TriLink Recent Developments/Updates
7.13.6 TriLink Competitive Strengths & Weaknesses
7.14 Azenta Life Science
7.14.1 Azenta Life Science Details
7.14.2 Azenta Life Science Major Business
7.14.3 Azenta Life Science RNA Oligonucleotide Synthesis Service Product and Services
7.14.4 Azenta Life Science RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Azenta Life Science Recent Developments/Updates
7.14.6 Azenta Life Science Competitive Strengths & Weaknesses
7.15 KareBay Biochem
7.15.1 KareBay Biochem Details
7.15.2 KareBay Biochem Major Business
7.15.3 KareBay Biochem RNA Oligonucleotide Synthesis Service Product and Services
7.15.4 KareBay Biochem RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 KareBay Biochem Recent Developments/Updates
7.15.6 KareBay Biochem Competitive Strengths & Weaknesses
7.16 Creative Biogene
7.16.1 Creative Biogene Details
7.16.2 Creative Biogene Major Business
7.16.3 Creative Biogene RNA Oligonucleotide Synthesis Service Product and Services
7.16.4 Creative Biogene RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Creative Biogene Recent Developments/Updates
7.16.6 Creative Biogene Competitive Strengths & Weaknesses
7.17 Generi Biotech
7.17.1 Generi Biotech Details
7.17.2 Generi Biotech Major Business
7.17.3 Generi Biotech RNA Oligonucleotide Synthesis Service Product and Services
7.17.4 Generi Biotech RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Generi Biotech Recent Developments/Updates
7.17.6 Generi Biotech Competitive Strengths & Weaknesses
7.18 Primetech
7.18.1 Primetech Details
7.18.2 Primetech Major Business
7.18.3 Primetech RNA Oligonucleotide Synthesis Service Product and Services
7.18.4 Primetech RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Primetech Recent Developments/Updates
7.18.6 Primetech Competitive Strengths & Weaknesses
7.19 General Biosystems
7.19.1 General Biosystems Details
7.19.2 General Biosystems Major Business
7.19.3 General Biosystems RNA Oligonucleotide Synthesis Service Product and Services
7.19.4 General Biosystems RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 General Biosystems Recent Developments/Updates
7.19.6 General Biosystems Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 RNA Oligonucleotide Synthesis Service Industry Chain
8.2 RNA Oligonucleotide Synthesis Service Upstream Analysis
8.3 RNA Oligonucleotide Synthesis Service Midstream Analysis
8.4 RNA Oligonucleotide Synthesis Service Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 RNA Oligonucleotide Synthesis Service Introduction
1.2 World RNA Oligonucleotide Synthesis Service Market Size & Forecast (2018 & 2022 & 2029)
1.3 World RNA Oligonucleotide Synthesis Service Total Market by Region (by Headquarter Location)
1.3.1 World RNA Oligonucleotide Synthesis Service Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States RNA Oligonucleotide Synthesis Service Market Size (2018-2029)
1.3.3 China RNA Oligonucleotide Synthesis Service Market Size (2018-2029)
1.3.4 Europe RNA Oligonucleotide Synthesis Service Market Size (2018-2029)
1.3.5 Japan RNA Oligonucleotide Synthesis Service Market Size (2018-2029)
1.3.6 South Korea RNA Oligonucleotide Synthesis Service Market Size (2018-2029)
1.3.7 ASEAN RNA Oligonucleotide Synthesis Service Market Size (2018-2029)
1.3.8 India RNA Oligonucleotide Synthesis Service Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 RNA Oligonucleotide Synthesis Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 RNA Oligonucleotide Synthesis Service Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029)
2.2 World RNA Oligonucleotide Synthesis Service Consumption Value by Region
2.2.1 World RNA Oligonucleotide Synthesis Service Consumption Value by Region (2018-2023)
2.2.2 World RNA Oligonucleotide Synthesis Service Consumption Value Forecast by Region (2024-2029)
2.3 United States RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029)
2.4 China RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029)
2.5 Europe RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029)
2.6 Japan RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029)
2.7 South Korea RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029)
2.8 ASEAN RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029)
2.9 India RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029)
3 WORLD RNA OLIGONUCLEOTIDE SYNTHESIS SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World RNA Oligonucleotide Synthesis Service Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global RNA Oligonucleotide Synthesis Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for RNA Oligonucleotide Synthesis Service in 2022
3.2.3 Global Concentration Ratios (CR8) for RNA Oligonucleotide Synthesis Service in 2022
3.3 RNA Oligonucleotide Synthesis Service Company Evaluation Quadrant
3.4 RNA Oligonucleotide Synthesis Service Market: Overall Company Footprint Analysis
3.4.1 RNA Oligonucleotide Synthesis Service Market: Region Footprint
3.4.2 RNA Oligonucleotide Synthesis Service Market: Company Product Type Footprint
3.4.3 RNA Oligonucleotide Synthesis Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: RNA Oligonucleotide Synthesis Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: RNA Oligonucleotide Synthesis Service Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: RNA Oligonucleotide Synthesis Service Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: RNA Oligonucleotide Synthesis Service Consumption Value Comparison
4.2.1 United States VS China: RNA Oligonucleotide Synthesis Service Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: RNA Oligonucleotide Synthesis Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based RNA Oligonucleotide Synthesis Service Companies and Market Share, 2018-2023
4.3.1 United States Based RNA Oligonucleotide Synthesis Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies RNA Oligonucleotide Synthesis Service Revenue, (2018-2023)
4.4 China Based Companies RNA Oligonucleotide Synthesis Service Revenue and Market Share, 2018-2023
4.4.1 China Based RNA Oligonucleotide Synthesis Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies RNA Oligonucleotide Synthesis Service Revenue, (2018-2023)
4.5 Rest of World Based RNA Oligonucleotide Synthesis Service Companies and Market Share, 2018-2023
4.5.1 Rest of World Based RNA Oligonucleotide Synthesis Service Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies RNA Oligonucleotide Synthesis Service Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World RNA Oligonucleotide Synthesis Service Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Standard Oligonucleotides
5.2.2 Micro-Oligonucleotides
5.2.3 Large-scale Oligonucleotides
5.2.4 Degenerate Primers
5.2.5 Long Oligos Synthesis
5.3 Market Segment by Type
5.3.1 World RNA Oligonucleotide Synthesis Service Market Size by Type (2018-2023)
5.3.2 World RNA Oligonucleotide Synthesis Service Market Size by Type (2024-2029)
5.3.3 World RNA Oligonucleotide Synthesis Service Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World RNA Oligonucleotide Synthesis Service Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Commercial
6.2.2 Academic Research
6.3 Market Segment by Application
6.3.1 World RNA Oligonucleotide Synthesis Service Market Size by Application (2018-2023)
6.3.2 World RNA Oligonucleotide Synthesis Service Market Size by Application (2024-2029)
6.3.3 World RNA Oligonucleotide Synthesis Service Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 GenScript
7.1.1 GenScript Details
7.1.2 GenScript Major Business
7.1.3 GenScript RNA Oligonucleotide Synthesis Service Product and Services
7.1.4 GenScript RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 GenScript Recent Developments/Updates
7.1.6 GenScript Competitive Strengths & Weaknesses
7.2 OriGene
7.2.1 OriGene Details
7.2.2 OriGene Major Business
7.2.3 OriGene RNA Oligonucleotide Synthesis Service Product and Services
7.2.4 OriGene RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 OriGene Recent Developments/Updates
7.2.6 OriGene Competitive Strengths & Weaknesses
7.3 BBI
7.3.1 BBI Details
7.3.2 BBI Major Business
7.3.3 BBI RNA Oligonucleotide Synthesis Service Product and Services
7.3.4 BBI RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 BBI Recent Developments/Updates
7.3.6 BBI Competitive Strengths & Weaknesses
7.4 Genewiz
7.4.1 Genewiz Details
7.4.2 Genewiz Major Business
7.4.3 Genewiz RNA Oligonucleotide Synthesis Service Product and Services
7.4.4 Genewiz RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Genewiz Recent Developments/Updates
7.4.6 Genewiz Competitive Strengths & Weaknesses
7.5 Eurofins Genomics
7.5.1 Eurofins Genomics Details
7.5.2 Eurofins Genomics Major Business
7.5.3 Eurofins Genomics RNA Oligonucleotide Synthesis Service Product and Services
7.5.4 Eurofins Genomics RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Eurofins Genomics Recent Developments/Updates
7.5.6 Eurofins Genomics Competitive Strengths & Weaknesses
7.6 Gene Oracle
7.6.1 Gene Oracle Details
7.6.2 Gene Oracle Major Business
7.6.3 Gene Oracle RNA Oligonucleotide Synthesis Service Product and Services
7.6.4 Gene Oracle RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Gene Oracle Recent Developments/Updates
7.6.6 Gene Oracle Competitive Strengths & Weaknesses
7.7 SBS Genetech
7.7.1 SBS Genetech Details
7.7.2 SBS Genetech Major Business
7.7.3 SBS Genetech RNA Oligonucleotide Synthesis Service Product and Services
7.7.4 SBS Genetech RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 SBS Genetech Recent Developments/Updates
7.7.6 SBS Genetech Competitive Strengths & Weaknesses
7.8 Creative Biolabs
7.8.1 Creative Biolabs Details
7.8.2 Creative Biolabs Major Business
7.8.3 Creative Biolabs RNA Oligonucleotide Synthesis Service Product and Services
7.8.4 Creative Biolabs RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Creative Biolabs Recent Developments/Updates
7.8.6 Creative Biolabs Competitive Strengths & Weaknesses
7.9 Bio Basic
7.9.1 Bio Basic Details
7.9.2 Bio Basic Major Business
7.9.3 Bio Basic RNA Oligonucleotide Synthesis Service Product and Services
7.9.4 Bio Basic RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Bio Basic Recent Developments/Updates
7.9.6 Bio Basic Competitive Strengths & Weaknesses
7.10 Kaneka Eurogentec SA
7.10.1 Kaneka Eurogentec SA Details
7.10.2 Kaneka Eurogentec SA Major Business
7.10.3 Kaneka Eurogentec SA RNA Oligonucleotide Synthesis Service Product and Services
7.10.4 Kaneka Eurogentec SA RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Kaneka Eurogentec SA Recent Developments/Updates
7.10.6 Kaneka Eurogentec SA Competitive Strengths & Weaknesses
7.11 AltaBioscience
7.11.1 AltaBioscience Details
7.11.2 AltaBioscience Major Business
7.11.3 AltaBioscience RNA Oligonucleotide Synthesis Service Product and Services
7.11.4 AltaBioscience RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 AltaBioscience Recent Developments/Updates
7.11.6 AltaBioscience Competitive Strengths & Weaknesses
7.12 Synbio Technologies
7.12.1 Synbio Technologies Details
7.12.2 Synbio Technologies Major Business
7.12.3 Synbio Technologies RNA Oligonucleotide Synthesis Service Product and Services
7.12.4 Synbio Technologies RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Synbio Technologies Recent Developments/Updates
7.12.6 Synbio Technologies Competitive Strengths & Weaknesses
7.13 TriLink
7.13.1 TriLink Details
7.13.2 TriLink Major Business
7.13.3 TriLink RNA Oligonucleotide Synthesis Service Product and Services
7.13.4 TriLink RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 TriLink Recent Developments/Updates
7.13.6 TriLink Competitive Strengths & Weaknesses
7.14 Azenta Life Science
7.14.1 Azenta Life Science Details
7.14.2 Azenta Life Science Major Business
7.14.3 Azenta Life Science RNA Oligonucleotide Synthesis Service Product and Services
7.14.4 Azenta Life Science RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Azenta Life Science Recent Developments/Updates
7.14.6 Azenta Life Science Competitive Strengths & Weaknesses
7.15 KareBay Biochem
7.15.1 KareBay Biochem Details
7.15.2 KareBay Biochem Major Business
7.15.3 KareBay Biochem RNA Oligonucleotide Synthesis Service Product and Services
7.15.4 KareBay Biochem RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 KareBay Biochem Recent Developments/Updates
7.15.6 KareBay Biochem Competitive Strengths & Weaknesses
7.16 Creative Biogene
7.16.1 Creative Biogene Details
7.16.2 Creative Biogene Major Business
7.16.3 Creative Biogene RNA Oligonucleotide Synthesis Service Product and Services
7.16.4 Creative Biogene RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Creative Biogene Recent Developments/Updates
7.16.6 Creative Biogene Competitive Strengths & Weaknesses
7.17 Generi Biotech
7.17.1 Generi Biotech Details
7.17.2 Generi Biotech Major Business
7.17.3 Generi Biotech RNA Oligonucleotide Synthesis Service Product and Services
7.17.4 Generi Biotech RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Generi Biotech Recent Developments/Updates
7.17.6 Generi Biotech Competitive Strengths & Weaknesses
7.18 Primetech
7.18.1 Primetech Details
7.18.2 Primetech Major Business
7.18.3 Primetech RNA Oligonucleotide Synthesis Service Product and Services
7.18.4 Primetech RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Primetech Recent Developments/Updates
7.18.6 Primetech Competitive Strengths & Weaknesses
7.19 General Biosystems
7.19.1 General Biosystems Details
7.19.2 General Biosystems Major Business
7.19.3 General Biosystems RNA Oligonucleotide Synthesis Service Product and Services
7.19.4 General Biosystems RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 General Biosystems Recent Developments/Updates
7.19.6 General Biosystems Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 RNA Oligonucleotide Synthesis Service Industry Chain
8.2 RNA Oligonucleotide Synthesis Service Upstream Analysis
8.3 RNA Oligonucleotide Synthesis Service Midstream Analysis
8.4 RNA Oligonucleotide Synthesis Service Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World RNA Oligonucleotide Synthesis Service Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World RNA Oligonucleotide Synthesis Service Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World RNA Oligonucleotide Synthesis Service Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World RNA Oligonucleotide Synthesis Service Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World RNA Oligonucleotide Synthesis Service Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World RNA Oligonucleotide Synthesis Service Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World RNA Oligonucleotide Synthesis Service Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World RNA Oligonucleotide Synthesis Service Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World RNA Oligonucleotide Synthesis Service Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key RNA Oligonucleotide Synthesis Service Players in 2022
Table 12. World RNA Oligonucleotide Synthesis Service Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global RNA Oligonucleotide Synthesis Service Company Evaluation Quadrant
Table 14. Head Office of Key RNA Oligonucleotide Synthesis Service Player
Table 15. RNA Oligonucleotide Synthesis Service Market: Company Product Type Footprint
Table 16. RNA Oligonucleotide Synthesis Service Market: Company Product Application Footprint
Table 17. RNA Oligonucleotide Synthesis Service Mergers & Acquisitions Activity
Table 18. United States VS China RNA Oligonucleotide Synthesis Service Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China RNA Oligonucleotide Synthesis Service Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based RNA Oligonucleotide Synthesis Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies RNA Oligonucleotide Synthesis Service Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies RNA Oligonucleotide Synthesis Service Revenue Market Share (2018-2023)
Table 23. China Based RNA Oligonucleotide Synthesis Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies RNA Oligonucleotide Synthesis Service Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies RNA Oligonucleotide Synthesis Service Revenue Market Share (2018-2023)
Table 26. Rest of World Based RNA Oligonucleotide Synthesis Service Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies RNA Oligonucleotide Synthesis Service Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies RNA Oligonucleotide Synthesis Service Revenue Market Share (2018-2023)
Table 29. World RNA Oligonucleotide Synthesis Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World RNA Oligonucleotide Synthesis Service Market Size by Type (2018-2023) & (USD Million)
Table 31. World RNA Oligonucleotide Synthesis Service Market Size by Type (2024-2029) & (USD Million)
Table 32. World RNA Oligonucleotide Synthesis Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World RNA Oligonucleotide Synthesis Service Market Size by Application (2018-2023) & (USD Million)
Table 34. World RNA Oligonucleotide Synthesis Service Market Size by Application (2024-2029) & (USD Million)
Table 35. GenScript Basic Information, Area Served and Competitors
Table 36. GenScript Major Business
Table 37. GenScript RNA Oligonucleotide Synthesis Service Product and Services
Table 38. GenScript RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. GenScript Recent Developments/Updates
Table 40. GenScript Competitive Strengths & Weaknesses
Table 41. OriGene Basic Information, Area Served and Competitors
Table 42. OriGene Major Business
Table 43. OriGene RNA Oligonucleotide Synthesis Service Product and Services
Table 44. OriGene RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. OriGene Recent Developments/Updates
Table 46. OriGene Competitive Strengths & Weaknesses
Table 47. BBI Basic Information, Area Served and Competitors
Table 48. BBI Major Business
Table 49. BBI RNA Oligonucleotide Synthesis Service Product and Services
Table 50. BBI RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. BBI Recent Developments/Updates
Table 52. BBI Competitive Strengths & Weaknesses
Table 53. Genewiz Basic Information, Area Served and Competitors
Table 54. Genewiz Major Business
Table 55. Genewiz RNA Oligonucleotide Synthesis Service Product and Services
Table 56. Genewiz RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Genewiz Recent Developments/Updates
Table 58. Genewiz Competitive Strengths & Weaknesses
Table 59. Eurofins Genomics Basic Information, Area Served and Competitors
Table 60. Eurofins Genomics Major Business
Table 61. Eurofins Genomics RNA Oligonucleotide Synthesis Service Product and Services
Table 62. Eurofins Genomics RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Eurofins Genomics Recent Developments/Updates
Table 64. Eurofins Genomics Competitive Strengths & Weaknesses
Table 65. Gene Oracle Basic Information, Area Served and Competitors
Table 66. Gene Oracle Major Business
Table 67. Gene Oracle RNA Oligonucleotide Synthesis Service Product and Services
Table 68. Gene Oracle RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Gene Oracle Recent Developments/Updates
Table 70. Gene Oracle Competitive Strengths & Weaknesses
Table 71. SBS Genetech Basic Information, Area Served and Competitors
Table 72. SBS Genetech Major Business
Table 73. SBS Genetech RNA Oligonucleotide Synthesis Service Product and Services
Table 74. SBS Genetech RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. SBS Genetech Recent Developments/Updates
Table 76. SBS Genetech Competitive Strengths & Weaknesses
Table 77. Creative Biolabs Basic Information, Area Served and Competitors
Table 78. Creative Biolabs Major Business
Table 79. Creative Biolabs RNA Oligonucleotide Synthesis Service Product and Services
Table 80. Creative Biolabs RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Creative Biolabs Recent Developments/Updates
Table 82. Creative Biolabs Competitive Strengths & Weaknesses
Table 83. Bio Basic Basic Information, Area Served and Competitors
Table 84. Bio Basic Major Business
Table 85. Bio Basic RNA Oligonucleotide Synthesis Service Product and Services
Table 86. Bio Basic RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Bio Basic Recent Developments/Updates
Table 88. Bio Basic Competitive Strengths & Weaknesses
Table 89. Kaneka Eurogentec SA Basic Information, Area Served and Competitors
Table 90. Kaneka Eurogentec SA Major Business
Table 91. Kaneka Eurogentec SA RNA Oligonucleotide Synthesis Service Product and Services
Table 92. Kaneka Eurogentec SA RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Kaneka Eurogentec SA Recent Developments/Updates
Table 94. Kaneka Eurogentec SA Competitive Strengths & Weaknesses
Table 95. AltaBioscience Basic Information, Area Served and Competitors
Table 96. AltaBioscience Major Business
Table 97. AltaBioscience RNA Oligonucleotide Synthesis Service Product and Services
Table 98. AltaBioscience RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. AltaBioscience Recent Developments/Updates
Table 100. AltaBioscience Competitive Strengths & Weaknesses
Table 101. Synbio Technologies Basic Information, Area Served and Competitors
Table 102. Synbio Technologies Major Business
Table 103. Synbio Technologies RNA Oligonucleotide Synthesis Service Product and Services
Table 104. Synbio Technologies RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Synbio Technologies Recent Developments/Updates
Table 106. Synbio Technologies Competitive Strengths & Weaknesses
Table 107. TriLink Basic Information, Area Served and Competitors
Table 108. TriLink Major Business
Table 109. TriLink RNA Oligonucleotide Synthesis Service Product and Services
Table 110. TriLink RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. TriLink Recent Developments/Updates
Table 112. TriLink Competitive Strengths & Weaknesses
Table 113. Azenta Life Science Basic Information, Area Served and Competitors
Table 114. Azenta Life Science Major Business
Table 115. Azenta Life Science RNA Oligonucleotide Synthesis Service Product and Services
Table 116. Azenta Life Science RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Azenta Life Science Recent Developments/Updates
Table 118. Azenta Life Science Competitive Strengths & Weaknesses
Table 119. KareBay Biochem Basic Information, Area Served and Competitors
Table 120. KareBay Biochem Major Business
Table 121. KareBay Biochem RNA Oligonucleotide Synthesis Service Product and Services
Table 122. KareBay Biochem RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. KareBay Biochem Recent Developments/Updates
Table 124. KareBay Biochem Competitive Strengths & Weaknesses
Table 125. Creative Biogene Basic Information, Area Served and Competitors
Table 126. Creative Biogene Major Business
Table 127. Creative Biogene RNA Oligonucleotide Synthesis Service Product and Services
Table 128. Creative Biogene RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Creative Biogene Recent Developments/Updates
Table 130. Creative Biogene Competitive Strengths & Weaknesses
Table 131. Generi Biotech Basic Information, Area Served and Competitors
Table 132. Generi Biotech Major Business
Table 133. Generi Biotech RNA Oligonucleotide Synthesis Service Product and Services
Table 134. Generi Biotech RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Generi Biotech Recent Developments/Updates
Table 136. Generi Biotech Competitive Strengths & Weaknesses
Table 137. Primetech Basic Information, Area Served and Competitors
Table 138. Primetech Major Business
Table 139. Primetech RNA Oligonucleotide Synthesis Service Product and Services
Table 140. Primetech RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Primetech Recent Developments/Updates
Table 142. General Biosystems Basic Information, Area Served and Competitors
Table 143. General Biosystems Major Business
Table 144. General Biosystems RNA Oligonucleotide Synthesis Service Product and Services
Table 145. General Biosystems RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 146. Global Key Players of RNA Oligonucleotide Synthesis Service Upstream (Raw Materials)
Table 147. RNA Oligonucleotide Synthesis Service Typical Customers
Table 1. World RNA Oligonucleotide Synthesis Service Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World RNA Oligonucleotide Synthesis Service Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World RNA Oligonucleotide Synthesis Service Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World RNA Oligonucleotide Synthesis Service Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World RNA Oligonucleotide Synthesis Service Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World RNA Oligonucleotide Synthesis Service Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World RNA Oligonucleotide Synthesis Service Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World RNA Oligonucleotide Synthesis Service Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World RNA Oligonucleotide Synthesis Service Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key RNA Oligonucleotide Synthesis Service Players in 2022
Table 12. World RNA Oligonucleotide Synthesis Service Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global RNA Oligonucleotide Synthesis Service Company Evaluation Quadrant
Table 14. Head Office of Key RNA Oligonucleotide Synthesis Service Player
Table 15. RNA Oligonucleotide Synthesis Service Market: Company Product Type Footprint
Table 16. RNA Oligonucleotide Synthesis Service Market: Company Product Application Footprint
Table 17. RNA Oligonucleotide Synthesis Service Mergers & Acquisitions Activity
Table 18. United States VS China RNA Oligonucleotide Synthesis Service Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China RNA Oligonucleotide Synthesis Service Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based RNA Oligonucleotide Synthesis Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies RNA Oligonucleotide Synthesis Service Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies RNA Oligonucleotide Synthesis Service Revenue Market Share (2018-2023)
Table 23. China Based RNA Oligonucleotide Synthesis Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies RNA Oligonucleotide Synthesis Service Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies RNA Oligonucleotide Synthesis Service Revenue Market Share (2018-2023)
Table 26. Rest of World Based RNA Oligonucleotide Synthesis Service Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies RNA Oligonucleotide Synthesis Service Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies RNA Oligonucleotide Synthesis Service Revenue Market Share (2018-2023)
Table 29. World RNA Oligonucleotide Synthesis Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World RNA Oligonucleotide Synthesis Service Market Size by Type (2018-2023) & (USD Million)
Table 31. World RNA Oligonucleotide Synthesis Service Market Size by Type (2024-2029) & (USD Million)
Table 32. World RNA Oligonucleotide Synthesis Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World RNA Oligonucleotide Synthesis Service Market Size by Application (2018-2023) & (USD Million)
Table 34. World RNA Oligonucleotide Synthesis Service Market Size by Application (2024-2029) & (USD Million)
Table 35. GenScript Basic Information, Area Served and Competitors
Table 36. GenScript Major Business
Table 37. GenScript RNA Oligonucleotide Synthesis Service Product and Services
Table 38. GenScript RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. GenScript Recent Developments/Updates
Table 40. GenScript Competitive Strengths & Weaknesses
Table 41. OriGene Basic Information, Area Served and Competitors
Table 42. OriGene Major Business
Table 43. OriGene RNA Oligonucleotide Synthesis Service Product and Services
Table 44. OriGene RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. OriGene Recent Developments/Updates
Table 46. OriGene Competitive Strengths & Weaknesses
Table 47. BBI Basic Information, Area Served and Competitors
Table 48. BBI Major Business
Table 49. BBI RNA Oligonucleotide Synthesis Service Product and Services
Table 50. BBI RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. BBI Recent Developments/Updates
Table 52. BBI Competitive Strengths & Weaknesses
Table 53. Genewiz Basic Information, Area Served and Competitors
Table 54. Genewiz Major Business
Table 55. Genewiz RNA Oligonucleotide Synthesis Service Product and Services
Table 56. Genewiz RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Genewiz Recent Developments/Updates
Table 58. Genewiz Competitive Strengths & Weaknesses
Table 59. Eurofins Genomics Basic Information, Area Served and Competitors
Table 60. Eurofins Genomics Major Business
Table 61. Eurofins Genomics RNA Oligonucleotide Synthesis Service Product and Services
Table 62. Eurofins Genomics RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Eurofins Genomics Recent Developments/Updates
Table 64. Eurofins Genomics Competitive Strengths & Weaknesses
Table 65. Gene Oracle Basic Information, Area Served and Competitors
Table 66. Gene Oracle Major Business
Table 67. Gene Oracle RNA Oligonucleotide Synthesis Service Product and Services
Table 68. Gene Oracle RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Gene Oracle Recent Developments/Updates
Table 70. Gene Oracle Competitive Strengths & Weaknesses
Table 71. SBS Genetech Basic Information, Area Served and Competitors
Table 72. SBS Genetech Major Business
Table 73. SBS Genetech RNA Oligonucleotide Synthesis Service Product and Services
Table 74. SBS Genetech RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. SBS Genetech Recent Developments/Updates
Table 76. SBS Genetech Competitive Strengths & Weaknesses
Table 77. Creative Biolabs Basic Information, Area Served and Competitors
Table 78. Creative Biolabs Major Business
Table 79. Creative Biolabs RNA Oligonucleotide Synthesis Service Product and Services
Table 80. Creative Biolabs RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Creative Biolabs Recent Developments/Updates
Table 82. Creative Biolabs Competitive Strengths & Weaknesses
Table 83. Bio Basic Basic Information, Area Served and Competitors
Table 84. Bio Basic Major Business
Table 85. Bio Basic RNA Oligonucleotide Synthesis Service Product and Services
Table 86. Bio Basic RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Bio Basic Recent Developments/Updates
Table 88. Bio Basic Competitive Strengths & Weaknesses
Table 89. Kaneka Eurogentec SA Basic Information, Area Served and Competitors
Table 90. Kaneka Eurogentec SA Major Business
Table 91. Kaneka Eurogentec SA RNA Oligonucleotide Synthesis Service Product and Services
Table 92. Kaneka Eurogentec SA RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Kaneka Eurogentec SA Recent Developments/Updates
Table 94. Kaneka Eurogentec SA Competitive Strengths & Weaknesses
Table 95. AltaBioscience Basic Information, Area Served and Competitors
Table 96. AltaBioscience Major Business
Table 97. AltaBioscience RNA Oligonucleotide Synthesis Service Product and Services
Table 98. AltaBioscience RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. AltaBioscience Recent Developments/Updates
Table 100. AltaBioscience Competitive Strengths & Weaknesses
Table 101. Synbio Technologies Basic Information, Area Served and Competitors
Table 102. Synbio Technologies Major Business
Table 103. Synbio Technologies RNA Oligonucleotide Synthesis Service Product and Services
Table 104. Synbio Technologies RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Synbio Technologies Recent Developments/Updates
Table 106. Synbio Technologies Competitive Strengths & Weaknesses
Table 107. TriLink Basic Information, Area Served and Competitors
Table 108. TriLink Major Business
Table 109. TriLink RNA Oligonucleotide Synthesis Service Product and Services
Table 110. TriLink RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. TriLink Recent Developments/Updates
Table 112. TriLink Competitive Strengths & Weaknesses
Table 113. Azenta Life Science Basic Information, Area Served and Competitors
Table 114. Azenta Life Science Major Business
Table 115. Azenta Life Science RNA Oligonucleotide Synthesis Service Product and Services
Table 116. Azenta Life Science RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Azenta Life Science Recent Developments/Updates
Table 118. Azenta Life Science Competitive Strengths & Weaknesses
Table 119. KareBay Biochem Basic Information, Area Served and Competitors
Table 120. KareBay Biochem Major Business
Table 121. KareBay Biochem RNA Oligonucleotide Synthesis Service Product and Services
Table 122. KareBay Biochem RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. KareBay Biochem Recent Developments/Updates
Table 124. KareBay Biochem Competitive Strengths & Weaknesses
Table 125. Creative Biogene Basic Information, Area Served and Competitors
Table 126. Creative Biogene Major Business
Table 127. Creative Biogene RNA Oligonucleotide Synthesis Service Product and Services
Table 128. Creative Biogene RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Creative Biogene Recent Developments/Updates
Table 130. Creative Biogene Competitive Strengths & Weaknesses
Table 131. Generi Biotech Basic Information, Area Served and Competitors
Table 132. Generi Biotech Major Business
Table 133. Generi Biotech RNA Oligonucleotide Synthesis Service Product and Services
Table 134. Generi Biotech RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Generi Biotech Recent Developments/Updates
Table 136. Generi Biotech Competitive Strengths & Weaknesses
Table 137. Primetech Basic Information, Area Served and Competitors
Table 138. Primetech Major Business
Table 139. Primetech RNA Oligonucleotide Synthesis Service Product and Services
Table 140. Primetech RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Primetech Recent Developments/Updates
Table 142. General Biosystems Basic Information, Area Served and Competitors
Table 143. General Biosystems Major Business
Table 144. General Biosystems RNA Oligonucleotide Synthesis Service Product and Services
Table 145. General Biosystems RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 146. Global Key Players of RNA Oligonucleotide Synthesis Service Upstream (Raw Materials)
Table 147. RNA Oligonucleotide Synthesis Service Typical Customers
LIST OF FIGURES
Figure 1. RNA Oligonucleotide Synthesis Service Picture
Figure 2. World RNA Oligonucleotide Synthesis Service Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World RNA Oligonucleotide Synthesis Service Total Market Size (2018-2029) & (USD Million)
Figure 4. World RNA Oligonucleotide Synthesis Service Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World RNA Oligonucleotide Synthesis Service Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company RNA Oligonucleotide Synthesis Service Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company RNA Oligonucleotide Synthesis Service Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company RNA Oligonucleotide Synthesis Service Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company RNA Oligonucleotide Synthesis Service Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company RNA Oligonucleotide Synthesis Service Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company RNA Oligonucleotide Synthesis Service Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company RNA Oligonucleotide Synthesis Service Revenue (2018-2029) & (USD Million)
Figure 13. RNA Oligonucleotide Synthesis Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029) & (USD Million)
Figure 16. World RNA Oligonucleotide Synthesis Service Consumption Value Market Share by Region (2018-2029)
Figure 17. United States RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029) & (USD Million)
Figure 18. China RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029) & (USD Million)
Figure 23. India RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of RNA Oligonucleotide Synthesis Service by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for RNA Oligonucleotide Synthesis Service Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for RNA Oligonucleotide Synthesis Service Markets in 2022
Figure 27. United States VS China: RNA Oligonucleotide Synthesis Service Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: RNA Oligonucleotide Synthesis Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World RNA Oligonucleotide Synthesis Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World RNA Oligonucleotide Synthesis Service Market Size Market Share by Type in 2022
Figure 31. Standard Oligonucleotides
Figure 32. Micro-Oligonucleotides
Figure 33. Large-scale Oligonucleotides
Figure 34. Degenerate Primers
Figure 35. Long Oligos Synthesis
Figure 36. World RNA Oligonucleotide Synthesis Service Market Size Market Share by Type (2018-2029)
Figure 37. World RNA Oligonucleotide Synthesis Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World RNA Oligonucleotide Synthesis Service Market Size Market Share by Application in 2022
Figure 39. Commercial
Figure 40. Academic Research
Figure 41. RNA Oligonucleotide Synthesis Service Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
Figure 1. RNA Oligonucleotide Synthesis Service Picture
Figure 2. World RNA Oligonucleotide Synthesis Service Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World RNA Oligonucleotide Synthesis Service Total Market Size (2018-2029) & (USD Million)
Figure 4. World RNA Oligonucleotide Synthesis Service Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World RNA Oligonucleotide Synthesis Service Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company RNA Oligonucleotide Synthesis Service Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company RNA Oligonucleotide Synthesis Service Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company RNA Oligonucleotide Synthesis Service Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company RNA Oligonucleotide Synthesis Service Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company RNA Oligonucleotide Synthesis Service Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company RNA Oligonucleotide Synthesis Service Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company RNA Oligonucleotide Synthesis Service Revenue (2018-2029) & (USD Million)
Figure 13. RNA Oligonucleotide Synthesis Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029) & (USD Million)
Figure 16. World RNA Oligonucleotide Synthesis Service Consumption Value Market Share by Region (2018-2029)
Figure 17. United States RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029) & (USD Million)
Figure 18. China RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029) & (USD Million)
Figure 23. India RNA Oligonucleotide Synthesis Service Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of RNA Oligonucleotide Synthesis Service by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for RNA Oligonucleotide Synthesis Service Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for RNA Oligonucleotide Synthesis Service Markets in 2022
Figure 27. United States VS China: RNA Oligonucleotide Synthesis Service Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: RNA Oligonucleotide Synthesis Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World RNA Oligonucleotide Synthesis Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World RNA Oligonucleotide Synthesis Service Market Size Market Share by Type in 2022
Figure 31. Standard Oligonucleotides
Figure 32. Micro-Oligonucleotides
Figure 33. Large-scale Oligonucleotides
Figure 34. Degenerate Primers
Figure 35. Long Oligos Synthesis
Figure 36. World RNA Oligonucleotide Synthesis Service Market Size Market Share by Type (2018-2029)
Figure 37. World RNA Oligonucleotide Synthesis Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World RNA Oligonucleotide Synthesis Service Market Size Market Share by Application in 2022
Figure 39. Commercial
Figure 40. Academic Research
Figure 41. RNA Oligonucleotide Synthesis Service Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
